142 related articles for article (PubMed ID: 38721281)
1. Identification of a lactate metabolism-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma.
Xu T; Liu Y; Ning B; Luo M; Wei Y
Transl Androl Urol; 2024 Apr; 13(4):509-525. PubMed ID: 38721281
[TBL] [Abstract][Full Text] [Related]
2. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Front Oncol; 2021; 11():663263. PubMed ID: 34123820
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
Front Immunol; 2022; 13():934387. PubMed ID: 35958561
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma.
Cai C; Shu K; Chen W; Ding J; Guo Z; Wei Y; Zhang W
Aging (Albany NY); 2023 Jun; 15(12):5304-5338. PubMed ID: 37379129
[TBL] [Abstract][Full Text] [Related]
6. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
Zhong S; Chen S; Lin H; Luo Y; He J
BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Anoiki-Related Lncrna Signature Prediction Model for KIRC Prognosis.
Su Y; Yang J
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38305400
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis.
Li D; Wu X; Song W; Cheng C; Hao L; Zhang W
Ann Transl Med; 2022 Nov; 10(22):1235. PubMed ID: 36544675
[TBL] [Abstract][Full Text] [Related]
10. Identification of autophagy-related long non-coding RNA prognostic and immune signature for clear cell renal cell carcinoma.
Cui Y; Zhang S; Miao C; Liang C; Chen X; Yan T; Bu H; Dong H; Li J; Li J; Wang Z; Liu B
Transl Androl Urol; 2021 Aug; 10(8):3317-3331. PubMed ID: 34532256
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma.
Chen J; Zhang D; Ren X; Wang P
Aging (Albany NY); 2023 Oct; 15(20):11012-11032. PubMed ID: 37847171
[TBL] [Abstract][Full Text] [Related]
12. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma.
Hong P; Huang W; Du H; Hu D; Cao Q; Wang Y; Zhang H; Tong S; Li Z; Tong M
Front Genet; 2022; 13():1009555. PubMed ID: 36406128
[No Abstract] [Full Text] [Related]
14. Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma.
Gao Y; Jia Z
Genet Res (Camb); 2022; 2022():6004852. PubMed ID: 36474620
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
Sun Z; Jing C; Xiao C; Li T
Front Oncol; 2020; 10():1430. PubMed ID: 32974157
[TBL] [Abstract][Full Text] [Related]
16. Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma.
Sun Z; Tao W; Guo X; Jing C; Zhang M; Wang Z; Kong F; Suo N; Jiang S; Wang H
Front Immunol; 2022; 13():818984. PubMed ID: 35250999
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
18. Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation.
Zhang X; Qin X; Yu T; Wang K; Chen Y; Xing Q
Front Genet; 2022; 13():974726. PubMed ID: 36338996
[No Abstract] [Full Text] [Related]
19. Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma.
Tang H; Chen H; Yuan H; Jin X; Chen G
Transl Cancer Res; 2022 Dec; 11(12):4254-4271. PubMed ID: 36644185
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma.
Fu S; Liu Y; Zhang Z; Mei M; Chen Q; Wang S; Yang X; Sun T; Ma M; Xie W
J Oncol; 2022; 2022():3487859. PubMed ID: 37342680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]